Stakeholders across the life sciences ecosystem are invited to attend the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place Sept. 9–11 at the Washington Marriott at Metro Center in Washington, D.C.

Nearly one in four teenagers are using dating apps — and it may not be hurting their mental health, suggests a new Northwestern Medicine study that monitored adolescents over six months. The findings challenge the popular belief that dating apps are harmful for teenagers. Instead, the study suggests, these apps may provide teens with valuable social connections, particularly for those who identify as sexual and gender minorities populations.

Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health, Pennington Biomedical Research Center, and Tulane University —  a tech-bio innovator using validated AI models to accelerate drug discovery from large-scale multiomics data —  to harness the power of artificial intelligence and one of the largest ALS datasets in the world.